Package | gov.healthit.ecqi.ecqms |
Resource Type | Measure |
Id | CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
FHIR Version | R4 |
Source | http://ecqi.healthit.gov/ecqms/https://build.fhir.org/ig/cqframework/ecqm-content-qicore-2025/Measure-CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer.html |
URL | https://madie.cms.gov/Measure/CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
Version | 1.5.000 |
Status | active |
Date | 2025-07-15T13:37:39+00:00 |
Name | CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
Title | Intravesical Bacillus-Calmette-Guerin for Non-Muscle Invasive Bladder CancerFHIR |
Description | Percentage of patients initially diagnosed with non-muscle invasive bladder cancer and who received intravesical Bacillus-Calmette-Guerin (BCG) within 6 months of bladder cancer staging |
Copyright | Limited proprietary coding is contained in the measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. Oregon Urology Institute (OUI) and Large Urology Group Practice Association (LUGPA) disclaim all liability for the use or accuracy of third party codes contained in the specifications. CPT(R) contained in the Measure specifications is copyright 2004-2024. American Medical Association. LOINC(R) copyright 2004-2024 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2024 International Health Terminology Standards Development Organisation. ICD-10 copyright 2024 World Health Organization. All Rights Reserved. |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
Metadata | |
---|---|
Title | Intravesical Bacillus-Calmette-Guerin for Non-Muscle Invasive Bladder CancerFHIR |
Version | 1.5.000 |
Short Name | CMS646FHIR |
GUID (Version Independent) | urn:uuid:907ead5a-2f8f-468e-b774-309ea8aa6182 |
GUID (Version Specific) | urn:uuid:de3ec699-6af3-4a85-9d3e-a0b487c66927 |
CMS Identifier | 646FHIR |
Effective Period | 2026-01-01 through 2026-12-31 |
Steward (Publisher) | Oregon Urology |
Developer | Oregon Urology |
Description | Percentage of patients initially diagnosed with non-muscle invasive bladder cancer and who received intravesical Bacillus-Calmette-Guerin (BCG) within 6 months of bladder cancer staging |
Copyright | Limited proprietary coding is contained in the measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. Oregon Urology Institute (OUI) and Large Urology Group Practice Association (LUGPA) disclaim all liability for the use or accuracy of third party codes contained in the specifications. CPT(R) contained in the Measure specifications is copyright 2004-2024. American Medical Association. LOINC(R) copyright 2004-2024 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2024 International Health Terminology Standards Development Organisation. ICD-10 copyright 2024 World Health Organization. All Rights Reserved. |
Disclaimer | The performance measure is not a clinical guideline and does not establish a standard of medical care, and has not been tested for all potential applications. THE MEASURES AND SPECIFICATIONS ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND. Due to technical limitations, registered trademarks are indicated by (R) or [R] and unregistered trademarks are indicated by TM or [TM]. |
Rationale | Bladder cancer is ranked 10th for new cancer cases in 2020 and is the ninth leading cause of cancer death in the United States. There are 81,400 estimated new cases in 2020 and 17,980 estimated deaths in 2020. In 2016, there were an estimated 699,450 people were living with bladder cancer in the United States. Early detection (discovery of cancer in situ or localized to the primary site) is found in 85% of the patients, and with these there is a five-year survival rate of 95.8% for In Situ and 69.2% for Localized. Bladder cancer is rarely found in patients under age 20, with the median age of diagnosis being 73 (NIH, 2020). National Comprehensive Cancer Network (NCCN) Guidelines for Bladder Cancer (version 6.2021) defines intravesical BCG as Category 1 Treatment for T1, Tis and Ta - high grade, non-muscle invasive bladder cancer. Most public data reflects prophylactic or adjuvant use of intravesical therapy to prevent recurrence or delaying progression to a higher grade or stage. BCG has been shown to be effective as prophylaxis to prevent bladder cancer recurrences following TURBT. The NCCN Bladder Cancer Panel Members recommend BCG as the preferred option over Mitomycin C for adjuvant treatment of high-grade lesions (Ta). BCG is also standard therapy for Primary Tis. Most T1 lesions are high-risk and are similarly treated with adjuvant intravesical therapy, with BCG being a Category 1 recommendation. (NCCN, 2021). |
Clinical Recommendation Statement | Intravesical BCG should be administered within 6 months of the initial diagnosis of non-muscle invasive bladder cancer. It may be administered 3-4 weeks after resection, but there needs to be pathological tumor confirmation and must be withheld if there is traumatic catheterization, bacteriuria, persistent gross hematuria, persistent severe local symptoms or systemic symptoms. The normal induction course is 6 weekly instillations of intravesical BCG (AUA Non-Muscle Invasive Bladder Cancer and American Urological Association (AUA) Guideline for the Management of Non-muscle Invasive Bladder Cancer: Stages T1, TIS, and Ta High Risk). |
Guidance (Usage) | Ta bladder cancer must be high grade Ta only and is supported by the 2016 AUA guidelines and 2018 NCCN guidelines. The BCG dose can be full or partial and can be from any lot or manufacturer. This eCQM is a patient-based measure. Telehealth encounters are not eligible for this measure because the measure requires a clinical action that cannot be conducted via telehealth This FHIR-based measure has been derived from the QDM-based measure: CMS646v5. Please refer to the HL7 QI-Core Implementation Guide (https://hl7.org/fhir/us/qicore/STU6/) for more information on QI-Core and mapping recommendations from QDM to QI-Core 6.0.0 (https://hl7.org/fhir/us/qicore/STU6/qdm-to-qicore.html). |
Measure Group (Rate) (ID: Group_1) | |
Basis | boolean |
Scoring | Proportion |
Type | Process |
Rate Aggregation | None |
Improvement Notation | Increased score indicates improvement |
Initial Population |
ID: InitialPopulation_1
Description: All patients initially diagnosed with T1, Tis or high grade Ta non-muscle invasive bladder cancer with bladder cancer staging within 6 months before to 6 months after the start of the measurement period and a qualified encounter in the measurement period Logic Definition: Initial Population |
Denominator |
ID: Denominator_1
Description: Equals Initial Population Logic Definition: Denominator |
Denominator Exclusion |
ID: DenominatorExclusion_1
Description: Immunosuppressed patients, includes HIV and immunocompromised state, with a diagnosis prior to Bladder Cancer Staging. Immunosuppressive drug therapy starting on or before Bladder Cancer Staging. Active Tuberculosis diagnosis during the Bladder Cancer Staging. Mixed histology urothelial cell carcinoma including micropapillary, plasmacytoid, sarcomatoid, adenocarcinoma and squamous disease prior to Bladder Cancer Staging. Patients who undergo cystectomy, chemotherapy or radiation within 6 months prior to Bladder Cancer Staging. Logic Definition: Denominator Exclusion |
Numerator |
ID: Numerator_1
Description: Intravesical Bacillus-Calmette Guerin (BCG) instillation for initial dose or series: BCG is initiated within 6 months of the bladder cancer staging Logic Definition: Numerator |
Denominator Exception |
ID: DenominatorException_1
Description: Unavailability of BCG within 6 months after Bladder Cancer Staging Logic Definition: Denominator Exception |
Supplemental Data Guidance | For every patient evaluated by this measure also identify payer, race, ethnicity and sex |
Supplemental Data Guidance | None |
Supplemental Data Elements | |
Supplemental Data Element |
ID: sde-ethnicity
Usage Code: Supplemental Data Description: SDE Ethnicity Logic Definition: SDE Ethnicity |
Supplemental Data Element |
ID: sde-payer
Usage Code: Supplemental Data Description: SDE Payer Logic Definition: SDE Payer |
Supplemental Data Element |
ID: sde-race
Usage Code: Supplemental Data Description: SDE Race Logic Definition: SDE Race |
Supplemental Data Element |
ID: sde-sex
Usage Code: Supplemental Data Description: SDE Sex Logic Definition: SDE Sex |
Supplemental Data Element |
ID: sde-race
Usage Code: Risk Adjustment Factor Description: SDE Race Logic Definition: SDE Race |
Supplemental Data Element |
ID: sde-payer
Usage Code: Risk Adjustment Factor Description: SDE Payer Logic Definition: SDE Payer |
Supplemental Data Element |
ID: sde-ethnicity
Usage Code: Risk Adjustment Factor Description: SDE Ethnicity Logic Definition: SDE Ethnicity |
Supplemental Data Element |
ID: sde-sex
Usage Code: Risk Adjustment Factor Description: SDE Sex Logic Definition: SDE Sex |
Measure Logic | |
Primary Library | CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
Contents |
Population Criteria
Logic Definitions Terminology Dependencies Data Requirements |
Population Criteria | |
Measure Group (Rate) (ID: Group_1) | |
Initial Population | |
|
|
Initial Population | |
|
|
Denominator | |
|
|
Denominator Exclusion | |
|
|
Numerator | |
|
|
Denominator Exception | |
|
|
Logic Definitions | |
Logic Definition | Library Name: SupplementalDataElements |
|
|
Logic Definition | Library Name: SupplementalDataElements |
|
|
Logic Definition | Library Name: SupplementalDataElements |
|
|
Logic Definition | Library Name: SupplementalDataElements |
|
|
Logic Definition | Library Name: CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
|
|
Logic Definition | Library Name: CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
|
|
Logic Definition | Library Name: CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
|
|
Logic Definition | Library Name: CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
|
|
Logic Definition | Library Name: CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
|
|
Logic Definition | Library Name: CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
|
|
Logic Definition | Library Name: CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
|
|
Logic Definition | Library Name: CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
|
|
Logic Definition | Library Name: CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
|
|
Logic Definition | Library Name: CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
|
|
Logic Definition | Library Name: CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
|
|
Logic Definition | Library Name: CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
|
|
Logic Definition | Library Name: CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
|
|
Logic Definition | Library Name: CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
|
|
Logic Definition | Library Name: CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
|
|
Logic Definition | Library Name: CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
|
|
Logic Definition | Library Name: CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
|
|
Logic Definition | Library Name: CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
|
|
Logic Definition | Library Name: CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
|
|
Logic Definition | Library Name: CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
|
|
Logic Definition | Library Name: CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
|
|
Logic Definition | Library Name: CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
|
|
Logic Definition | Library Name: CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
|
|
Logic Definition | Library Name: CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
|
|
Logic Definition | Library Name: CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer |
|
|
Logic Definition | Library Name: QICoreCommon |
|
|
Logic Definition | Library Name: QICoreCommon |
|
|
Logic Definition | Library Name: FHIRHelpers |
|
|
Logic Definition | Library Name: FHIRHelpers |
|
|
Logic Definition | Library Name: FHIRHelpers |
|
|
Terminology | |
Code System |
Description: Code system SNOMEDCT
Resource: SNOMED CT (all versions) Canonical URL: http://snomed.info/sct |
Code System |
Description: Code system SNOMEDCT
Resource: SNOMED CT (all versions) Canonical URL: http://snomed.info/sct |
Code System |
Description: Code system ConditionVerificationStatusCodes
Resource: ConditionVerificationStatus Canonical URL: http://terminology.hl7.org/CodeSystem/condition-ver-status |
Code System |
Description: Code system ICD10CM
Resource: International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) Canonical URL: http://hl7.org/fhir/sid/icd-10-cm |
Code System |
Description: Code system ActCode
Resource: ActCode Canonical URL: http://terminology.hl7.org/CodeSystem/v3-ActCode |
Value Set |
Description: Value set Bacillus Calmette Guerin for Urology Care
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.353
Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.353 |
Value Set |
Description: Value set Bladder Cancer for Urology Care
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.354
Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.354 |
Value Set |
Description: Value set Office Visit
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1001
Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1001 |
Value Set |
Description: Value set Payer Type
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591
Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591 |
Value Set |
Description: Value set Tuberculosis for Urology Care
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.351
Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.351 |
Value Set |
Description: Value set Immunosuppressive Drugs for Urology Care
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.364
Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.364 |
Value Set |
Description: Value set Cystectomy for Urology Care
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.358
Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.358 |
Value Set |
Description: Value set HIV
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.120.12.1003
Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.120.12.1003 |
Value Set |
Description: Value set Immunocompromised Conditions
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.363
Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.363 |
Value Set |
Description: Value set Mixed Histology Urothelial Cell Carcinoma for Urology Care
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.365
Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.365 |
Value Set |
Description: Value set Chemotherapy Agents for Advanced Cancer
Resource: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.355
Canonical URL: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.355 |
Direct Reference Code |
Display: Male (finding)
Code: 248153007 System: http://snomed.info/sct |
Direct Reference Code |
Display: Female (finding)
Code: 248152002 System: http://snomed.info/sct |
Direct Reference Code |
Display: Tumor staging (tumor staging)
Code: 254292007 System: http://snomed.info/sct |
Direct Reference Code |
Display: Confirmed
Code: confirmed System: http://terminology.hl7.org/CodeSystem/condition-ver-status |
Direct Reference Code |
Display: American Joint Committee on Cancer cT1 (qualifier value)
Code: 1228889001 System: http://snomed.info/sct |
Direct Reference Code |
Display: American Joint Committee on Cancer cTis (qualifier value)
Code: 1228884006 System: http://snomed.info/sct |
Direct Reference Code |
Display: American Joint Committee on Cancer cTa (qualifier value)
Code: 1228883000 System: http://snomed.info/sct |
Direct Reference Code |
Display: Carcinoma in situ of bladder
Code: D09.0 System: http://hl7.org/fhir/sid/icd-10-cm |
Direct Reference Code |
Display: virtual
Code: VR System: http://terminology.hl7.org/CodeSystem/v3-ActCode |
Direct Reference Code |
Display: Combined radiotherapy (procedure)
Code: 169331000 System: http://snomed.info/sct |
Dependencies | |
Dependency |
Description: Library SDE
Resource: Library/SupplementalDataElements|5.1.000
Canonical URL: Library/SupplementalDataElements|5.1.000 |
Dependency |
Description: Library FHIRHelpers
Resource: Library/FHIRHelpers|4.4.000
Canonical URL: Library/FHIRHelpers|4.4.000 |
Dependency |
Description: Library FHIRHelpers
Resource: Library/FHIRHelpers|4.4.000
Canonical URL: Library/FHIRHelpers|4.4.000 |
Dependency |
Description: Library QICoreCommon
Resource: Library/QICoreCommon|4.0.000
Canonical URL: Library/QICoreCommon|4.0.000 |
Data Requirements | |
Data Requirement |
Type: Condition
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-problems-health-concerns
Must Support Elements: code Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.354
|
Data Requirement |
Type: Condition
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-encounter-diagnosis
Must Support Elements: code Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.354
|
Data Requirement |
Type: Patient
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient
|
Data Requirement |
Type: Procedure
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-procedure
Must Support Elements: code, performed, status, status.value Code Filter(s): Path: code Code(s): SNOMED CT 254292007: Tumor staging (tumor staging) |
Data Requirement |
Type: MedicationAdministration
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationadministration
Must Support Elements: medication Code Filter(s): Path: medication ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.353
|
Data Requirement |
Type: MedicationAdministration
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationadministration
Must Support Elements: medication.reference.value |
Data Requirement |
Type: Observation
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation-lab
Must Support Elements: value, status, status.value |
Data Requirement |
Type: Encounter
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-encounter
Must Support Elements: type, period, class, status, status.value Code Filter(s): Path: type ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1001
|
Data Requirement |
Type: Condition
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-problems-health-concerns
Must Support Elements: code Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.351
|
Data Requirement |
Type: Condition
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-encounter-diagnosis
Must Support Elements: code Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.351
|
Data Requirement |
Type: MedicationRequest
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationrequest
Must Support Elements: medication Code Filter(s): Path: medication ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.364
|
Data Requirement |
Type: Procedure
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-procedure
Must Support Elements: code, performed, status, status.value Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.358
|
Data Requirement |
Type: Condition
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-problems-health-concerns
Must Support Elements: code Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.120.12.1003
|
Data Requirement |
Type: Condition
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-encounter-diagnosis
Must Support Elements: code Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.120.12.1003
|
Data Requirement |
Type: Condition
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-problems-health-concerns
Must Support Elements: code Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.363
|
Data Requirement |
Type: Condition
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-encounter-diagnosis
Must Support Elements: code Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.363
|
Data Requirement |
Type: Condition
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-problems-health-concerns
Must Support Elements: code Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.365
|
Data Requirement |
Type: Condition
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-encounter-diagnosis
Must Support Elements: code Code Filter(s): Path: code ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.365
|
Data Requirement |
Type: MedicationRequest
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationrequest
Must Support Elements: medication Code Filter(s): Path: medication ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.355
|
Data Requirement |
Type: MedicationRequest
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationrequest
Must Support Elements: medication.reference.value |
Data Requirement |
Type: Medication
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medication
Must Support Elements: id.value, code |
Data Requirement |
Type: Procedure
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-procedure
Must Support Elements: code, performed, status, status.value Code Filter(s): Path: code Code(s): SNOMED CT 169331000: Combined radiotherapy (procedure) |
Data Requirement |
Type: Patient
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient
Must Support Elements: url |
Data Requirement |
Type: Coverage
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-coverage
Must Support Elements: type, period Code Filter(s): Path: type ValueSet: http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591
|
Data Requirement |
Type: Patient
Profile(s): http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient
Must Support Elements: url, extension |
Generated using version 0.4.8 of the sample-content-ig Liquid templates |
{ "resourceType": "Measure", "id": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer", "meta": { "profile": [ "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareablemeasure", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-measure-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-measure-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/executable-measure-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cql-measure-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/elm-measure-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/proportion-measure-cqfm" ] }, "text": { "status": "extensions", "div": "<!-- snip (see above) -->" }, "contained": [ { "resourceType": "Library", "id": "effective-data-requirements", "extension": [ { "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-directReferenceCode", "valueCoding": { "system": "http://snomed.info/sct", "code": "248153007", "display": "Male (finding)" } }, { "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-directReferenceCode", "valueCoding": { "system": "http://snomed.info/sct", "code": "248152002", "display": "Female (finding)" } }, { "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-directReferenceCode", "valueCoding": { "system": "http://snomed.info/sct", "code": "254292007", "display": "Tumor staging (tumor staging)" } }, { "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-directReferenceCode", "valueCoding": { "system": "http://terminology.hl7.org/CodeSystem/condition-ver-status", "code": "confirmed", "display": "Confirmed" } }, { "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-directReferenceCode", "valueCoding": { "system": "http://snomed.info/sct", "code": "1228889001", "display": "American Joint Committee on Cancer cT1 (qualifier value)" } }, { "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-directReferenceCode", "valueCoding": { "system": "http://snomed.info/sct", "code": "1228884006", "display": "American Joint Committee on Cancer cTis (qualifier value)" } }, { "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-directReferenceCode", "valueCoding": { "system": "http://snomed.info/sct", "code": "1228883000", "display": "American Joint Committee on Cancer cTa (qualifier value)" } }, { "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-directReferenceCode", "valueCoding": { "system": "http://hl7.org/fhir/sid/icd-10-cm", "code": "D09.0", "display": "Carcinoma in situ of bladder" } }, { "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-directReferenceCode", "valueCoding": { "system": "http://terminology.hl7.org/CodeSystem/v3-ActCode", "code": "VR", "display": "virtual" } }, { "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-directReferenceCode", "valueCoding": { "system": "http://snomed.info/sct", "code": "169331000", "display": "Combined radiotherapy (procedure)" } }, { "extension": [ { "url": "libraryName", "valueString": "SupplementalDataElements" }, { "url": "name", "valueString": "SDE Sex" }, { "url": "statement", "valueString": "define \"SDE Sex\":\n case\n when Patient.sex = '248153007' then \"Male (finding)\"\n when Patient.sex = '248152002' then \"Female (finding)\"\n else null\n end" }, { "url": "displaySequence", "valueInteger": 0 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer" }, { "url": "name", "valueString": "SDE Sex" }, { "url": "statement", "valueString": "define \"SDE Sex\":\n SDE.\"SDE Sex\"" }, { "url": "displaySequence", "valueInteger": 1 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer" }, { "url": "name", "valueString": "Bladder Cancer Diagnosis" }, { "url": "statement", "valueString": "define \"Bladder Cancer Diagnosis\":\n ( [ConditionProblemsHealthConcerns: \"Bladder Cancer for Urology Care\"]\n union [ConditionEncounterDiagnosis: \"Bladder Cancer for Urology Care\"] ) BladderCancer\n where BladderCancer.prevalenceInterval ( ) starts before day of end of \"Measurement Period\"\n and BladderCancer.isConfirmedActiveDiagnosis ( )" }, { "url": "displaySequence", "valueInteger": 2 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer" }, { "url": "name", "valueString": "First Bladder Cancer Staging Procedure" }, { "url": "statement", "valueString": "define \"First Bladder Cancer Staging Procedure\":\n First([Procedure: \"Tumor staging (tumor staging)\"] BladderCancerStaging\n with \"Bladder Cancer Diagnosis\" BladderCancer\n such that BladderCancerStaging.performed.toInterval() starts on or before day of start of BladderCancer.prevalenceInterval()\n where BladderCancerStaging.status = 'completed'\n sort by start of performed.toInterval()\n )" }, { "url": "displaySequence", "valueInteger": 3 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer" }, { "url": "name", "valueString": "First BCG Administered" }, { "url": "statement", "valueString": "define \"First BCG Administered\":\n First([MedicationAdministration: \"Bacillus Calmette Guerin for Urology Care\"] BCG\n with \"First Bladder Cancer Staging Procedure\" FirstBladderCancerStaging\n such that BCG.effective.toInterval() starts 6 months or less after day of start of FirstBladderCancerStaging.performed.toInterval()\n and BCG.effective.toInterval() starts during \"Measurement Period\"\n where BCG.status in { 'in-progress', 'completed' }\n sort by start of effective.toInterval()\n )" }, { "url": "displaySequence", "valueInteger": 4 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer" }, { "url": "name", "valueString": "Numerator" }, { "url": "statement", "valueString": "define \"Numerator\":\n \"First BCG Administered\" is not null" }, { "url": "displaySequence", "valueInteger": 5 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer" }, { "url": "name", "valueString": "Denominator Exception" }, { "url": "statement", "valueString": "/*\n@commentedOut: exists \"BCG Not Available Within 6 Months After Bladder Cancer Staging\"\n@commentedOutReason: Negation issue related to https://github.com/cqframework/cql-execution/issues/296, which is tied to https://oncprojectracking.healthit.gov/support/browse/BONNIEMAT-1455. Due to this being the only logic in this population added 'false' as a placeholder.\n*/\n\n\ndefine \"Denominator Exception\":\n false" }, { "url": "displaySequence", "valueInteger": 6 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer" }, { "url": "name", "valueString": "July 1 of Year Prior to the Measurement Period" }, { "url": "statement", "valueString": "define \"July 1 of Year Prior to the Measurement Period\":\n DateTime((year from start of \"Measurement Period\" - 1), 7, 1, 0, 0, 0, 0, 0)" }, { "url": "displaySequence", "valueInteger": 7 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer" }, { "url": "name", "valueString": "June 30 of the Measurement Period" }, { "url": "statement", "valueString": "define \"June 30 of the Measurement Period\":\n DateTime((year from start of \"Measurement Period\"), 6, 30, 23, 59, 59, 0, 0)" }, { "url": "displaySequence", "valueInteger": 8 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer" }, { "url": "name", "valueString": "First Bladder Cancer Staging Procedure during 6 Months Prior to Measurement Period through the First 6 Months of Measurement Period" }, { "url": "statement", "valueString": "define \"First Bladder Cancer Staging Procedure during 6 Months Prior to Measurement Period through the First 6 Months of Measurement Period\":\n \"First Bladder Cancer Staging Procedure\" FirstBladderCancerStaging\n where FirstBladderCancerStaging.performed.toInterval ( ) during day of Interval[\"July 1 of Year Prior to the Measurement Period\", \"June 30 of the Measurement Period\"]" }, { "url": "displaySequence", "valueInteger": 9 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer" }, { "url": "name", "valueString": "Has Most Recent Bladder Cancer Tumor Staging is T1, Tis, Ta HG" }, { "url": "statement", "valueString": "/*Ta High Grade only to be included. Ta low grade is to be excluded from this measure.*/\n\n\ndefine \"Has Most Recent Bladder Cancer Tumor Staging is T1, Tis, Ta HG\":\n exists ( [LaboratoryResultObservation] StagingObservation\n where StagingObservation.getStagingProcedure ( ) is not null\n and ( StagingObservation.value as Concept ~ \"American Joint Committee on Cancer cT1 (qualifier value)\"\n or StagingObservation.value as Concept ~ \"American Joint Committee on Cancer cTis (qualifier value)\"\n or StagingObservation.value as Concept ~ \"American Joint Committee on Cancer cTa (qualifier value)\"\n or StagingObservation.value as Concept ~ \"Carcinoma in situ of bladder\"\n )\n and StagingObservation.status in { 'final', 'amended', 'corrected' }\n )" }, { "url": "displaySequence", "valueInteger": 10 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer" }, { "url": "name", "valueString": "Has Qualifying Encounter" }, { "url": "statement", "valueString": "define \"Has Qualifying Encounter\":\n exists ( [Encounter: \"Office Visit\"] ValidEncounter\n where ValidEncounter.period during \"Measurement Period\"\n and ValidEncounter.class !~ \"virtual\"\n and ValidEncounter.status = 'finished'\n )" }, { "url": "displaySequence", "valueInteger": 11 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer" }, { "url": "name", "valueString": "Initial Population" }, { "url": "statement", "valueString": "define \"Initial Population\":\n \"Has Most Recent Bladder Cancer Tumor Staging is T1, Tis, Ta HG\"\n and \"Has Qualifying Encounter\"" }, { "url": "displaySequence", "valueInteger": 12 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer" }, { "url": "name", "valueString": "Denominator" }, { "url": "statement", "valueString": "define \"Denominator\":\n \"Initial Population\"" }, { "url": "displaySequence", "valueInteger": 13 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "SupplementalDataElements" }, { "url": "name", "valueString": "SDE Payer" }, { "url": "statement", "valueString": "define \"SDE Payer\":\n [Coverage: type in \"Payer Type\"] Payer\n return {\n code: Payer.type,\n period: Payer.period\n }" }, { "url": "displaySequence", "valueInteger": 14 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer" }, { "url": "name", "valueString": "SDE Payer" }, { "url": "statement", "valueString": "define \"SDE Payer\":\n SDE.\"SDE Payer\"" }, { "url": "displaySequence", "valueInteger": 15 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer" }, { "url": "name", "valueString": "Initial Population" }, { "url": "statement", "valueString": "define \"Initial Population\":\n \"Has Most Recent Bladder Cancer Tumor Staging is T1, Tis, Ta HG\"\n and \"Has Qualifying Encounter\"" }, { "url": "displaySequence", "valueInteger": 16 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "SupplementalDataElements" }, { "url": "name", "valueString": "SDE Ethnicity" }, { "url": "statement", "valueString": "define \"SDE Ethnicity\":\n Patient.ethnicity E\n return Tuple {\n codes: { E.ombCategory } union E.detailed,\n display: E.text\n }" }, { "url": "displaySequence", "valueInteger": 17 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer" }, { "url": "name", "valueString": "SDE Ethnicity" }, { "url": "statement", "valueString": "define \"SDE Ethnicity\":\n SDE.\"SDE Ethnicity\"" }, { "url": "displaySequence", "valueInteger": 18 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer" }, { "url": "name", "valueString": "Acute Tuberculosis Diagnosis" }, { "url": "statement", "valueString": "define \"Acute Tuberculosis Diagnosis\":\n ( [ConditionProblemsHealthConcerns: \"Tuberculosis for Urology Care\"]\n union [ConditionEncounterDiagnosis: \"Tuberculosis for Urology Care\"] ) ActiveTuberculosis\n with \"First Bladder Cancer Staging Procedure\" FirstBladderCancerStaging\n such that ActiveTuberculosis.prevalenceInterval ( ) overlaps after day of FirstBladderCancerStaging.performed.toInterval ( )\n where ActiveTuberculosis.isConfirmedActiveDiagnosis ( )" }, { "url": "displaySequence", "valueInteger": 19 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer" }, { "url": "name", "valueString": "Immunosuppressive Drugs" }, { "url": "statement", "valueString": "define \"Immunosuppressive Drugs\":\n [MedicationRequest: \"Immunosuppressive Drugs for Urology Care\"] ImmunosuppressiveDrugs\n let firstMedicationPeriod: First((collapse(ImmunosuppressiveDrugs.dosageInstruction.timing.repeat.bounds DoseTime\n return DoseTime.toInterval()\n )) DrugPeriods\n sort by start of $this\n ),\n //get the very first event\n \n firstMedicationEvent: First((ImmunosuppressiveDrugs.dosageInstruction.timing dosageTiming\n //return first event for the specific dosageTiming\n \n return First(dosageTiming.event dosageTimingEvents\n sort ascending\n )) firstEvents\n sort ascending\n ),\n medicationPeriod: Coalesce(firstMedicationEvent.toInterval(), firstMedicationPeriod)\n with \"First Bladder Cancer Staging Procedure\" FirstBladderCancerStaging\n such that medicationPeriod starts on or before day of start of FirstBladderCancerStaging.performed.toInterval ( )\n where ImmunosuppressiveDrugs.status in { 'active', 'completed' }\n and ImmunosuppressiveDrugs.intent = 'order'" }, { "url": "displaySequence", "valueInteger": 20 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer" }, { "url": "name", "valueString": "Cystectomy Done" }, { "url": "statement", "valueString": "define \"Cystectomy Done\":\n [Procedure: \"Cystectomy for Urology Care\"] Cystectomy\n with \"First Bladder Cancer Staging Procedure\" FirstBladderCancerStaging\n such that Cystectomy.performed.toInterval ( ) 6 months or less before day of start of FirstBladderCancerStaging.performed.toInterval ( )\n where Cystectomy.status = 'completed'" }, { "url": "displaySequence", "valueInteger": 21 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer" }, { "url": "name", "valueString": "Has Excluding HIV, Immunocompromised Conditions or Mixed Histology Before Staging" }, { "url": "statement", "valueString": "define \"Has Excluding HIV, Immunocompromised Conditions or Mixed Histology Before Staging\":\n exists ( ( ( [ConditionProblemsHealthConcerns: \"HIV\"]\n union [ConditionEncounterDiagnosis: \"HIV\"]\n )\n union ( [ConditionProblemsHealthConcerns: \"Immunocompromised Conditions\"]\n union [ConditionEncounterDiagnosis: \"Immunocompromised Conditions\"]\n )\n union ( [ConditionProblemsHealthConcerns: \"Mixed Histology Urothelial Cell Carcinoma for Urology Care\"]\n union [ConditionEncounterDiagnosis: \"Mixed Histology Urothelial Cell Carcinoma for Urology Care\"]\n ) ) ExclusionDiagnosis\n with \"First Bladder Cancer Staging Procedure\" FirstBladderCancerStaging\n such that ExclusionDiagnosis.prevalenceInterval ( ) starts on or before day of start of FirstBladderCancerStaging.performed.toInterval ( )\n where ExclusionDiagnosis.isConfirmedActiveDiagnosis ( )\n )" }, { "url": "displaySequence", "valueInteger": 22 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer" }, { "url": "name", "valueString": "Has Excluding Chemotherapy or Radiotherapy Procedure Before Staging" }, { "url": "statement", "valueString": "define \"Has Excluding Chemotherapy or Radiotherapy Procedure Before Staging\":\n exists ( ( [MedicationRequest: \"Chemotherapy Agents for Advanced Cancer\"] ExclusionMed\n let firstMedicationPeriod: First((collapse(ExclusionMed.dosageInstruction.timing.repeat.bounds DoseTime\n return DoseTime.toInterval()\n )) DrugPeriods\n sort by start of $this\n )\n with \"First Bladder Cancer Staging Procedure\" FirstBladderCancerStaging\n such that firstMedicationPeriod starts 6 months or less before FirstBladderCancerStaging.performed.toInterval ( )\n where ExclusionMed.status in { 'active', 'completed' }\n and ExclusionMed.intent = 'order'\n )\n union ( [Procedure: \"Combined radiotherapy (procedure)\"] ExclusionProcedure\n with \"First Bladder Cancer Staging Procedure\" FirstBladderCancerStaging\n such that ExclusionProcedure.performed.toInterval ( ) starts 6 months or less before FirstBladderCancerStaging.performed.toInterval ( )\n where ExclusionProcedure.status = 'completed'\n )\n )" }, { "url": "displaySequence", "valueInteger": 23 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer" }, { "url": "name", "valueString": "Denominator Exclusion" }, { "url": "statement", "valueString": "define \"Denominator Exclusion\":\n exists \"Acute Tuberculosis Diagnosis\"\n or exists \"Immunosuppressive Drugs\"\n or exists \"Cystectomy Done\"\n or \"Has Excluding HIV, Immunocompromised Conditions or Mixed Histology Before Staging\"\n or \"Has Excluding Chemotherapy or Radiotherapy Procedure Before Staging\"" }, { "url": "displaySequence", "valueInteger": 24 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "SupplementalDataElements" }, { "url": "name", "valueString": "SDE Race" }, { "url": "statement", "valueString": "define \"SDE Race\":\n Patient.race R\n return Tuple {\n codes: R.ombCategory union R.detailed,\n display: R.text\n }" }, { "url": "displaySequence", "valueInteger": 25 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer" }, { "url": "name", "valueString": "SDE Race" }, { "url": "statement", "valueString": "define \"SDE Race\":\n SDE.\"SDE Race\"" }, { "url": "displaySequence", "valueInteger": 26 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "FHIRHelpers" }, { "url": "name", "valueString": "ToString" }, { "url": "statement", "valueString": "define function ToString(value uri): value.value" }, { "url": "displaySequence", "valueInteger": 27 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer" }, { "url": "name", "valueString": "isConfirmedActiveDiagnosis" }, { "url": "statement", "valueString": "define fluent function isConfirmedActiveDiagnosis(Condition Choice<ConditionProblemsHealthConcerns, ConditionEncounterDiagnosis>):\n Condition.isActive ( )\n and Condition.verificationStatus ~ QICoreCommon.\"confirmed\"" }, { "url": "displaySequence", "valueInteger": 28 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "QICoreCommon" }, { "url": "name", "valueString": "toInterval" }, { "url": "statement", "valueString": "/*\n@description: Normalizes a value that is a choice of timing-valued types to an equivalent interval\n@comment: Normalizes a choice type of DateTime, Quanitty, Interval<DateTime>, or Interval<Quantity> types\nto an equivalent interval. This selection of choice types is a superset of the majority of choice types that are used as possible\nrepresentations for timing-valued elements in QICore, allowing this function to be used across any resource.\nThe input can be provided as a DateTime, Quantity, Interval<DateTime> or Interval<Quantity>.\nThe intent of this function is to provide a clear and concise mechanism to treat single\nelements that have multiple possible representations as intervals so that logic doesn't have to account\nfor the variability. More complex calculations (such as medication request period or dispense period\ncalculation) need specific guidance and consideration. That guidance may make use of this function, but\nthe focus of this function is on single element calculations where the semantics are unambiguous.\nIf the input is a DateTime, the result a DateTime Interval beginning and ending on that DateTime.\nIf the input is a Quantity, the quantity is expected to be a calendar-duration interpreted as an Age,\nand the result is a DateTime Interval beginning on the Date the patient turned that age and ending immediately before one year later.\nIf the input is a DateTime Interval, the result is the input.\nIf the input is a Quantity Interval, the quantities are expected to be calendar-durations interpreted as an Age, and the result\nis a DateTime Interval beginning on the date the patient turned the age given as the start of the quantity interval, and ending\nimmediately before one year later than the date the patient turned the age given as the end of the quantity interval.\nIf the input is a Timing, an error will be thrown indicating that Timing calculations are not implemented. Any other input will reslt in a null DateTime Interval\n*/\ndefine fluent function toInterval(choice Choice<DateTime, Quantity, Interval<DateTime>, Interval<Quantity>, Timing>):\n case\n\t when choice is DateTime then\n \tInterval[choice as DateTime, choice as DateTime]\n\t\twhen choice is Interval<DateTime> then\n \t\tchoice as Interval<DateTime>\n\t\twhen choice is Quantity then\n\t\t Interval[Patient.birthDate + (choice as Quantity),\n\t\t\t Patient.birthDate + (choice as Quantity) + 1 year)\n\t\twhen choice is Interval<Quantity> then\n\t\t Interval[Patient.birthDate + (choice.low as Quantity),\n\t\t\t Patient.birthDate + (choice.high as Quantity) + 1 year)\n\t\twhen choice is Timing then\n Message(null, true, 'NOT_IMPLEMENTED', 'Error', 'Calculation of an interval from a Timing value is not supported') as Interval<DateTime>\n\t\telse\n\t\t\tnull as Interval<DateTime>\n\tend" }, { "url": "displaySequence", "valueInteger": 29 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer" }, { "url": "name", "valueString": "getStagingProcedure" }, { "url": "statement", "valueString": "define fluent function getStagingProcedure(StagingObservation LaboratoryResultObservation):\n StagingObservation.partOf StagingReference\n return \"First Bladder Cancer Staging Procedure during 6 Months Prior to Measurement Period through the First 6 Months of Measurement Period\" FirstBladderCancerStagingMP\n where FirstBladderCancerStagingMP.id = StagingReference.reference.getId ( )" }, { "url": "displaySequence", "valueInteger": 30 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "QICoreCommon" }, { "url": "name", "valueString": "getId" }, { "url": "statement", "valueString": "/*\n@description: Returns the tail of the given uri (i.e. everything after the last slash in the URI).\n@comment: This function can be used to determine the logical id of a given resource. It can be used in\na single-server environment to trace references. However, this function does not attempt to resolve\nor distinguish the base of the given url, and so cannot be used safely in multi-server environments.\n*/\ndefine fluent function getId(uri String):\n Last(Split(uri, '/'))" }, { "url": "displaySequence", "valueInteger": 31 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "FHIRHelpers" }, { "url": "name", "valueString": "ToInterval" }, { "url": "statement", "valueString": "/*\n@description: Converts the given [Period](https://hl7.org/fhir/datatypes.html#Period)\nvalue to a CQL DateTime Interval\n@comment: If the start value of the given period is unspecified, the starting\nboundary of the resulting interval will be open (meaning the start of the interval\nis unknown, as opposed to interpreted as the beginning of time).\n*/\ndefine function ToInterval(period FHIR.Period):\n if period is null then\n null\n else\n if period.\"start\" is null then\n Interval(period.\"start\".value, period.\"end\".value]\n else\n Interval[period.\"start\".value, period.\"end\".value]" }, { "url": "displaySequence", "valueInteger": 32 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" }, { "extension": [ { "url": "libraryName", "valueString": "FHIRHelpers" }, { "url": "name", "valueString": "ToCode" }, { "url": "statement", "valueString": "/*\n@description: Converts the given FHIR [Coding](https://hl7.org/fhir/datatypes.html#Coding) value to a CQL Code.\n*/\ndefine function ToCode(coding FHIR.Coding):\n if coding is null then\n null\n else\n System.Code {\n code: coding.code.value,\n system: coding.system.value,\n version: coding.version.value,\n display: coding.display.value\n }" }, { "url": "displaySequence", "valueInteger": 33 } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-logicDefinition" } ], "name": "EffectiveDataRequirements", "status": "active", "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/library-type", "code": "module-definition" } ] }, "relatedArtifact": [ { "type": "depends-on", "display": "Library SDE", "resource": "Library/SupplementalDataElements|5.1.000" }, { "type": "depends-on", "display": "Library FHIRHelpers", "resource": "Library/FHIRHelpers|4.4.000" }, { "type": "depends-on", "display": "Library FHIRHelpers", "resource": "Library/FHIRHelpers|4.4.000" }, { "type": "depends-on", "display": "Library QICoreCommon", "resource": "Library/QICoreCommon|4.0.000" }, { "type": "depends-on", "display": "Code system SNOMEDCT", "resource": "http://snomed.info/sct" }, { "type": "depends-on", "display": "Code system SNOMEDCT", "resource": "http://snomed.info/sct" }, { "type": "depends-on", "display": "Code system ConditionVerificationStatusCodes", "resource": "http://terminology.hl7.org/CodeSystem/condition-ver-status" }, { "type": "depends-on", "display": "Code system ICD10CM", "resource": "http://hl7.org/fhir/sid/icd-10-cm" }, { "type": "depends-on", "display": "Code system ActCode", "resource": "http://terminology.hl7.org/CodeSystem/v3-ActCode" }, { "type": "depends-on", "display": "Value set Bacillus Calmette Guerin for Urology Care", "resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.353" }, { "type": "depends-on", "display": "Value set Bladder Cancer for Urology Care", "resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.354" }, { "type": "depends-on", "display": "Value set Office Visit", "resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1001" }, { "type": "depends-on", "display": "Value set Payer Type", "resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591" }, { "type": "depends-on", "display": "Value set Tuberculosis for Urology Care", "resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.351" }, { "type": "depends-on", "display": "Value set Immunosuppressive Drugs for Urology Care", "resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.364" }, { "type": "depends-on", "display": "Value set Cystectomy for Urology Care", "resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.358" }, { "type": "depends-on", "display": "Value set HIV", "resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.120.12.1003" }, { "type": "depends-on", "display": "Value set Immunocompromised Conditions", "resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.363" }, { "type": "depends-on", "display": "Value set Mixed Histology Urothelial Cell Carcinoma for Urology Care", "resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.365" }, { "type": "depends-on", "display": "Value set Chemotherapy Agents for Advanced Cancer", "resource": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.355" } ], "parameter": [ { "name": "Measurement Period", "use": "in", "min": 0, "max": "1", "type": "Period" }, { "name": "SDE Sex", "use": "out", "min": 0, "max": "1", "type": "Coding" }, { "name": "Numerator", "use": "out", "min": 0, "max": "1", "type": "boolean" }, { "name": "Denominator Exception", "use": "out", "min": 0, "max": "1", "type": "boolean" }, { "name": "Denominator", "use": "out", "min": 0, "max": "1", "type": "boolean" }, { "name": "SDE Payer", "use": "out", "min": 0, "max": "*", "type": "Resource" }, { "name": "Initial Population", "use": "out", "min": 0, "max": "1", "type": "boolean" }, { "name": "SDE Ethnicity", "use": "out", "min": 0, "max": "1", "type": "Resource" }, { "name": "Denominator Exclusion", "use": "out", "min": 0, "max": "1", "type": "boolean" }, { "name": "SDE Race", "use": "out", "min": 0, "max": "1", "type": "Resource" } ], "dataRequirement": [ { "type": "Patient", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient" ] }, { "type": "Patient", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient" ], "mustSupport": [ "url", "value.value" ] }, { "type": "Patient", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient" ], "mustSupport": [ "url", "value.value" ] }, { "type": "Condition", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-problems-health-concerns" ], "mustSupport": [ "code" ], "codeFilter": [ { "path": "code", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.354" } ] }, { "type": "Condition", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-encounter-diagnosis" ], "mustSupport": [ "code" ], "codeFilter": [ { "path": "code", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.354" } ] }, { "type": "Patient", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient" ] }, { "type": "Procedure", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-procedure" ], "mustSupport": [ "code", "performed", "status", "status.value" ], "codeFilter": [ { "path": "code", "code": [ { "system": "http://snomed.info/sct", "code": "254292007", "display": "Tumor staging (tumor staging)" } ] } ] }, { "type": "MedicationAdministration", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationadministration" ], "mustSupport": [ "medication" ], "codeFilter": [ { "path": "medication", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.353" } ] }, { "type": "MedicationAdministration", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationadministration" ], "mustSupport": [ "medication.reference.value" ] }, { "type": "Medication", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medication" ], "mustSupport": [ "id.value", "code" ] }, { "type": "Observation", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation-lab" ], "mustSupport": [ "value", "status", "status.value" ] }, { "type": "Encounter", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-encounter" ], "mustSupport": [ "type", "period", "class", "status", "status.value" ], "codeFilter": [ { "path": "type", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.12.1001" } ] }, { "type": "Coverage", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-coverage" ], "mustSupport": [ "type", "period" ], "codeFilter": [ { "path": "type", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591" } ] }, { "type": "Patient", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient" ], "mustSupport": [ "url" ] }, { "type": "Patient", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient" ], "mustSupport": [ "url", "extension" ] }, { "type": "Condition", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-problems-health-concerns" ], "mustSupport": [ "code" ], "codeFilter": [ { "path": "code", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.351" } ] }, { "type": "Condition", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-encounter-diagnosis" ], "mustSupport": [ "code" ], "codeFilter": [ { "path": "code", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.351" } ] }, { "type": "MedicationRequest", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationrequest" ], "mustSupport": [ "medication" ], "codeFilter": [ { "path": "medication", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.364" } ] }, { "type": "MedicationRequest", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationrequest" ], "mustSupport": [ "medication.reference.value" ] }, { "type": "Medication", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medication" ], "mustSupport": [ "id.value", "code" ] }, { "type": "Procedure", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-procedure" ], "mustSupport": [ "code", "performed", "status", "status.value" ], "codeFilter": [ { "path": "code", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.358" } ] }, { "type": "Condition", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-problems-health-concerns" ], "mustSupport": [ "code" ], "codeFilter": [ { "path": "code", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.120.12.1003" } ] }, { "type": "Condition", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-encounter-diagnosis" ], "mustSupport": [ "code" ], "codeFilter": [ { "path": "code", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.120.12.1003" } ] }, { "type": "Condition", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-problems-health-concerns" ], "mustSupport": [ "code" ], "codeFilter": [ { "path": "code", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.363" } ] }, { "type": "Condition", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-encounter-diagnosis" ], "mustSupport": [ "code" ], "codeFilter": [ { "path": "code", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.363" } ] }, { "type": "Condition", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-problems-health-concerns" ], "mustSupport": [ "code" ], "codeFilter": [ { "path": "code", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.365" } ] }, { "type": "Condition", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition-encounter-diagnosis" ], "mustSupport": [ "code" ], "codeFilter": [ { "path": "code", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.365" } ] }, { "type": "MedicationRequest", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationrequest" ], "mustSupport": [ "medication" ], "codeFilter": [ { "path": "medication", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.355" } ] }, { "type": "MedicationRequest", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medicationrequest" ], "mustSupport": [ "medication.reference.value" ] }, { "type": "Medication", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-medication" ], "mustSupport": [ "id.value", "code" ] }, { "type": "Procedure", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-procedure" ], "mustSupport": [ "code", "performed", "status", "status.value" ], "codeFilter": [ { "path": "code", "code": [ { "system": "http://snomed.info/sct", "code": "169331000", "display": "Combined radiotherapy (procedure)" } ] } ] }, { "type": "Patient", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient" ], "mustSupport": [ "url" ] }, { "type": "Patient", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient" ], "mustSupport": [ "url", "extension" ] }, { "type": "Coverage", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-coverage" ], "mustSupport": [ "type", "period" ], "codeFilter": [ { "path": "type", "valueSet": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591" } ] }, { "type": "Patient", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient" ], "mustSupport": [ "url", "extension" ] }, { "type": "Patient", "profile": [ "http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient" ], "mustSupport": [ "url", "extension" ] } ] } ], "extension": [ { "id": "supplementalDataGuidance", "extension": [ { "url": "guidance", "valueString": "For every patient evaluated by this measure also identify payer, race, ethnicity and sex" }, { "url": "usage", "valueCodeableConcept": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-data-usage", "code": "supplemental-data", "display": "Supplemental Data" } ], "text": "Supplemental Data Guidance" } } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-supplementalDataGuidance" }, { "id": "riskAdjustmentVariableGuidance", "extension": [ { "url": "guidance", "valueString": "None" }, { "url": "usage", "valueCodeableConcept": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-data-usage", "code": "risk-adjustment-factor", "display": "Risk Adjustment Factor" } ], "text": "Risk Adjustment Variable Guidance" } } ], "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-supplementalDataGuidance" }, { "url": "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-effectiveDataRequirements", "valueCanonical": "#effective-data-requirements" }, { "id": "effective-data-requirements", "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-effectiveDataRequirements", "valueReference": { "reference": "#effective-data-requirements" } } ], "url": "https://madie.cms.gov/Measure/CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer", "identifier": [ { "use": "usual", "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/artifact-identifier-type", "code": "short-name", "display": "Short Name" } ] }, "system": "https://madie.cms.gov/measure/shortName", "value": "CMS646FHIR" }, { "use": "official", "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/artifact-identifier-type", "code": "version-independent", "display": "Version Independent" } ] }, "system": "urn:ietf:rfc:3986", "value": "urn:uuid:907ead5a-2f8f-468e-b774-309ea8aa6182" }, { "use": "official", "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/artifact-identifier-type", "code": "version-specific", "display": "Version Specific" } ] }, "system": "urn:ietf:rfc:3986", "value": "urn:uuid:de3ec699-6af3-4a85-9d3e-a0b487c66927" }, { "use": "official", "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/artifact-identifier-type", "code": "publisher", "display": "Publisher" } ] }, "system": "https://madie.cms.gov/measure/cmsId", "value": "646FHIR", "assigner": { "display": "CMS" } } ], "version": "1.5.000", "name": "CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer", "title": "Intravesical Bacillus-Calmette-Guerin for Non-Muscle Invasive Bladder CancerFHIR", "status": "active", "experimental": false, "date": "2025-07-15T13:37:39+00:00", "publisher": "Oregon Urology", "contact": [ { "telecom": [ { "system": "url", "value": "www.oregonurology.com" } ] } ], "description": "Percentage of patients initially diagnosed with non-muscle invasive bladder cancer and who received intravesical Bacillus-Calmette-Guerin (BCG) within 6 months of bladder cancer staging", "usage": "Ta bladder cancer must be high grade Ta only and is supported by the 2016 AUA guidelines and 2018 NCCN guidelines.\n\nThe BCG dose can be full or partial and can be from any lot or manufacturer.\n\nThis eCQM is a patient-based measure.\n\nTelehealth encounters are not eligible for this measure because the measure requires a clinical action that cannot be conducted via telehealth\n\nThis FHIR-based measure has been derived from the QDM-based measure: CMS646v5.\n \nPlease refer to the HL7 QI-Core Implementation Guide (https://hl7.org/fhir/us/qicore/STU6/) for more information on QI-Core and mapping recommendations from QDM to QI-Core 6.0.0 (https://hl7.org/fhir/us/qicore/STU6/qdm-to-qicore.html).", "copyright": "Limited proprietary coding is contained in the measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. Oregon Urology Institute (OUI) and Large Urology Group Practice Association (LUGPA) disclaim all liability for the use or accuracy of third party codes contained in the specifications.\n\nCPT(R) contained in the Measure specifications is copyright 2004-2024. American Medical Association. LOINC(R) copyright 2004-2024 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2024 International Health Terminology Standards Development Organisation. ICD-10 copyright 2024 World Health Organization. All Rights Reserved.", "effectivePeriod": { "start": "2026-01-01", "end": "2026-12-31" }, "author": [ { "name": "Oregon Urology", "telecom": [ { "system": "url", "value": "www.oregonurology.com" } ] } ], "library": [ "https://madie.cms.gov/Library/CMS646FHIRIntravesicalBacillusCalmetteGuerinForBladderCancer" ], "disclaimer": "The performance measure is not a clinical guideline and does not establish a standard of medical care, and has not been tested for all potential applications.\n\nTHE MEASURES AND SPECIFICATIONS ARE PROVIDED \"AS IS\" WITHOUT WARRANTY OF ANY KIND.\n\nDue to technical limitations, registered trademarks are indicated by (R) or [R] and unregistered trademarks are indicated by TM or [TM].", "rationale": "Bladder cancer is ranked 10th for new cancer cases in 2020 and is the ninth leading cause of cancer death in the United States. There are 81,400 estimated new cases in 2020 and 17,980 estimated deaths in 2020. In 2016, there were an estimated 699,450 people were living with bladder cancer in the United States. Early detection (discovery of cancer in situ or localized to the primary site) is found in 85% of the patients, and with these there is a five-year survival rate of 95.8% for In Situ and 69.2% for Localized. Bladder cancer is rarely found in patients under age 20, with the median age of diagnosis being 73 (NIH, 2020).\nNational Comprehensive Cancer Network (NCCN) Guidelines for Bladder Cancer (version 6.2021) defines intravesical BCG as Category 1 Treatment for T1, Tis and Ta - high grade, non-muscle invasive bladder cancer. Most public data reflects prophylactic or adjuvant use of intravesical therapy to prevent recurrence or delaying progression to a higher grade or stage. BCG has been shown to be effective as prophylaxis to prevent bladder cancer recurrences following TURBT. The NCCN Bladder Cancer Panel Members recommend BCG as the preferred option over Mitomycin C for adjuvant treatment of high-grade lesions (Ta). BCG is also standard therapy for Primary Tis. Most T1 lesions are high-risk and are similarly treated with adjuvant intravesical therapy, with BCG being a Category 1 recommendation. (NCCN, 2021).", "clinicalRecommendationStatement": "Intravesical BCG should be administered within 6 months of the initial diagnosis of non-muscle invasive bladder cancer. It may be administered 3-4 weeks after resection, but there needs to be pathological tumor confirmation and must be withheld if there is traumatic catheterization, bacteriuria, persistent gross hematuria, persistent severe local symptoms or systemic symptoms. The normal induction course is 6 weekly instillations of intravesical BCG (AUA Non-Muscle Invasive Bladder Cancer and American Urological Association (AUA) Guideline for the Management of Non-muscle Invasive Bladder Cancer: Stages T1, TIS, and Ta High Risk).", "definition": [ "Bacillus Calmette-Guerin (BCG) - A live attenuated strain of Mycobacterium bovis, first indicated as a tuberculosis vaccine, has had widespread use in intravesical immunotherapy since the 1970's.\n", "Histology - urothelial carcinoma\n", "Intravescial - Within the urinary bladder\n", "Primary Tumor (T) stage - T1 - The tumor invades subepithelial connective tissue (high grade or low grade)\n", "Primary Tumor (T) stage - Ta - Noninvasive and high grade\n", "Primary Tumor (T) stage - Tis - Carcinoma in situ: \"flat tumor\"\n", "Tumor location - urinary bladder\n" ], "guidance": "Ta bladder cancer must be high grade Ta only and is supported by the 2016 AUA guidelines and 2018 NCCN guidelines.\n\nThe BCG dose can be full or partial and can be from any lot or manufacturer.\n\nThis eCQM is a patient-based measure.\n\nTelehealth encounters are not eligible for this measure because the measure requires a clinical action that cannot be conducted via telehealth\n\nThis FHIR-based measure has been derived from the QDM-based measure: CMS646v5.\n \nPlease refer to the HL7 QI-Core Implementation Guide (https://hl7.org/fhir/us/qicore/STU6/) for more information on QI-Core and mapping recommendations from QDM to QI-Core 6.0.0 (https://hl7.org/fhir/us/qicore/STU6/qdm-to-qicore.html).", "group": [ { "id": "Group_1", "extension": [ { "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-scoring", "valueCodeableConcept": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-scoring", "code": "proportion", "display": "Proportion" } ] } }, { "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-populationBasis", "valueCode": "boolean" }, { "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-type", "valueCodeableConcept": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-type", "code": "process", "display": "Process" } ] } }, { "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-rateAggregation", "valueCode": "None" }, { "url": "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-improvementNotation", "valueCodeableConcept": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-improvement-notation", "code": "increase", "display": "Increased score indicates improvement" } ] } } ], "population": [ { "id": "InitialPopulation_1", "code": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-population", "code": "initial-population", "display": "Initial Population" } ] }, "description": "All patients initially diagnosed with T1, Tis or high grade Ta non-muscle invasive bladder cancer with bladder cancer staging within 6 months before to 6 months after the start of the measurement period and a qualified encounter in the measurement period", "criteria": { "language": "text/cql-identifier", "expression": "Initial Population" } }, { "id": "Denominator_1", "code": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-population", "code": "denominator", "display": "Denominator" } ] }, "description": "Equals Initial Population", "criteria": { "language": "text/cql-identifier", "expression": "Denominator" } }, { "id": "DenominatorExclusion_1", "code": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-population", "code": "denominator-exclusion", "display": "Denominator Exclusion" } ] }, "description": "Immunosuppressed patients, includes HIV and immunocompromised state, with a diagnosis prior to Bladder Cancer Staging.\n\nImmunosuppressive drug therapy starting on or before Bladder Cancer Staging.\n\nActive Tuberculosis diagnosis during the Bladder Cancer Staging.\n\nMixed histology urothelial cell carcinoma including micropapillary, plasmacytoid, sarcomatoid, adenocarcinoma and squamous disease prior to Bladder Cancer Staging.\n\nPatients who undergo cystectomy, chemotherapy or radiation within 6 months prior to Bladder Cancer Staging.", "criteria": { "language": "text/cql-identifier", "expression": "Denominator Exclusion" } }, { "id": "Numerator_1", "code": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-population", "code": "numerator", "display": "Numerator" } ] }, "description": "Intravesical Bacillus-Calmette Guerin (BCG) instillation for initial dose or series:\nBCG is initiated within 6 months of the bladder cancer staging", "criteria": { "language": "text/cql-identifier", "expression": "Numerator" } }, { "id": "DenominatorException_1", "code": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-population", "code": "denominator-exception", "display": "Denominator Exception" } ] }, "description": "Unavailability of BCG within 6 months after Bladder Cancer Staging", "criteria": { "language": "text/cql-identifier", "expression": "Denominator Exception" } } ] } ], "supplementalData": [ { "id": "sde-ethnicity", "usage": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-data-usage", "code": "supplemental-data" } ] } ], "description": "SDE Ethnicity", "criteria": { "language": "text/cql-identifier", "expression": "SDE Ethnicity" } }, { "id": "sde-payer", "usage": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-data-usage", "code": "supplemental-data" } ] } ], "description": "SDE Payer", "criteria": { "language": "text/cql-identifier", "expression": "SDE Payer" } }, { "id": "sde-race", "usage": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-data-usage", "code": "supplemental-data" } ] } ], "description": "SDE Race", "criteria": { "language": "text/cql-identifier", "expression": "SDE Race" } }, { "id": "sde-sex", "usage": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-data-usage", "code": "supplemental-data" } ] } ], "description": "SDE Sex", "criteria": { "language": "text/cql-identifier", "expression": "SDE Sex" } }, { "id": "sde-race", "usage": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-data-usage", "code": "risk-adjustment-factor" } ] } ], "description": "SDE Race", "criteria": { "language": "text/cql-identifier", "expression": "SDE Race" } }, { "id": "sde-payer", "usage": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-data-usage", "code": "risk-adjustment-factor" } ] } ], "description": "SDE Payer", "criteria": { "language": "text/cql-identifier", "expression": "SDE Payer" } }, { "id": "sde-ethnicity", "usage": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-data-usage", "code": "risk-adjustment-factor" } ] } ], "description": "SDE Ethnicity", "criteria": { "language": "text/cql-identifier", "expression": "SDE Ethnicity" } }, { "id": "sde-sex", "usage": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/measure-data-usage", "code": "risk-adjustment-factor" } ] } ], "description": "SDE Sex", "criteria": { "language": "text/cql-identifier", "expression": "SDE Sex" } } ] }